9th Annual Biomarkers Congress

Immunology: Pfizer

Total Score People Score Events Score
16 15 14
Date Event Presentation Speakers
April 28, 2014 Companion Diagnostics: From Biomarker Identification to Market Entry Case Study: Xalkori Companion Diagnostic Hakan Sakul
October 3, 2010 4th Vaccine and ISV Annual Global Congress The development of Prevenar 13: A second-generation vccine for the prevention of pneumococcal disease Emilio Emini
August 24, 2010 Enabling Point-of-Care Diagnostics - Moving Towards Rapid Diagnosis Chairperson’s Remarks Hakan Sakul
May 20, 2010 Antibody Optimization Antibody-Drug Conjugates to Improve Therapeutic Index Wei Liao
Optimization of a Monoclonal Antibody for Improved Anti-Tumor Efficacy Gerald Casperson
Chairperson’s Opening Remarks Gerald Casperson
May 19, 2010 Pre-Clinical / Clinical Development of Therapeutic Antibodies Species Selection: The Foundation of the Nonclinical Toxicology Program Marque Todd
October 13, 2009 2009 PDA/EMEA Joint Conference: Ensuring Patient Safety through Supply Chain Control and GMP Orientation to Parallel Tracks Véronique Davoust
Session 2 : Survey of current and pending European legislation and guidance on GMP and supply chain Véronique Davoust
Official welcome, background of the conference, goals, recognition of planning committee. Véronique Davoust
S1: Counterfeiting & Supply Chain: European Legislation ~ Véronique Davoust
Summary of Key Points and Issues from Parallel Tracks Véronique Davoust
August 18, 2009 Inaugural Novel Vaccines: Adjuvants & Delivery Systems Enhancing Vaccine Immunogenicity Through Use of TLR9 Agonists Risini D. Weeratna
Chairperson’s Remarks Bilikallahalli Muralidhara
Formulation and Stability of DNA (Plasmid) Based Therapeutics Bilikallahalli Muralidhara
June 3, 2009 Inaugural Drug Induced Liver Injury Development of animal models of idiosyncratic DILI using genomic signatures of susceptibility Husam S Younis
February 9, 2009 Immunogenicity for Biologics 2009 Neutralising antibody assays: Competitive ligand binding assays vs. bioassays Deborah Finco Kent
January 28, 2009 Clinical Trials for Special Populations Successfully navigating the ethics committee Adrian Liepins
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Title: TBD :Track 2-3 Yuan-Hua Ding
October 28, 2008 Bridging Pharma and IT Making Open Access Instrumentation Open to All Brian Bissett
September 17, 2008 BACULOVIRUS TECHNOLOGY Parallel Protein Production in the Baculovirus Expression Vector System for Structure-Based Drug Design Ciaran Cronin
September 26, 2007 EuroBio2007 (Sep 26th - 28th) BIOTECH ECONOMY AND BUSINESS DEVELOPMENT (09:00 - 18:30) Ruth Keir
BIOTECH ECONOMY AND BUSINESS DEVELOPMENT: What types of opportunities are pharmaceutical companies looking to invest in ? Biotech / Pharma: Case studies. (14:00 - 16:00) Ruth Keir
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.